Senators grilled CEOs of seven major drug companies on Tuesday over high prescription drug prices that are a drain on Medicare and Medicaid and a burden to millions of Americans. The extraordinary public accounting was a sign that Congress and…

By Ricardo Alonso-Zaldivar, Matthew Perrone, Associated Press

Medicare has zillions of rules. But there's one more that columnist Philip Moeller would like to see adopted. Right now, Medicare beneficiaries are pawns in the drug pricing system, and plenty of Americans don't take the drugs they need because…

By Philip Moeller

Pfizer made a $106 billion bid for the British drug maker AstraZeneca this week in a move that was potentially motivated by lower corporate tax rates overseas. The deal could also affect the development of new drugs. Hari Sreenivasan speaks…

By PBS NewsHour

Judy Woodruff talks with the National Law Journal's Marcia Coyle about the Supreme Court's 6-2 ruling making it more difficult for parents who say their children were injured by vaccines to file lawsuits against drug makers.